Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of botulinum toxin injection into masseter muscle to lower face appearance and masticatory function
TCTR20240617001Phase 0Completed
- Sponsor
- Mahidol University
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 0, single-arm trial of neuronox in None and Masticatory Muscle Hypertrophy (MMH), sponsored by Mahidol University. Primary endpoints: Lower face appearance and Masticatory function. Started Jul 2024; status: completed.
02
Drugs
neuronox
03
Conditions
Masticatory Muscle Hypertrophy (MMH)
Beyond the preview
Go deeper on TCTR20240617001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240617001.